Agile Sciences, Inc — Form D
Agile Sciences, Inc of Raleigh, NC, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-29. The offering totals $5.0M, of which $1.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-05-29
- Form: D
- Accession: 0001419641-20-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.0M
- Remaining: $4.0M
- Investors: 1
- Date of first sale: 2020-05-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-367898
Issuer
- Name: Agile Sciences, Inc
- CIK: 0001419641
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 1791 VARSITY DRIVE, SUITE 150, Raleigh, NC, 27606
- Phone: 919-457-3308
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| John Cavanagh | Director | Raleigh, NC |
| Bill Culpepper | Director | Raleigh, NC |
| Christian Melander | Director | Raleigh, NC |
| Malcolm Thomas | Director | Raleigh, NC |
| Steven Young | Director | Delafield, WI |
| Malcolm Thomas | Executive Officer | Raleigh, NC |
| David LaVance | Director | Morrisville, NC |
| Christian Melander | Executive Officer | Raleigh, NC |
| John Cavanagh | Executive Officer | Raleigh, NC |
| KEITH STONEBACK | Director | PHOENIX, AZ |
| Harry Garland | Director | Raleigh, NC |
| Stephen Brand | Executive Officer | Raleigh, NC |
Other filings by this issuer (1)
More